Cargando…
2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection
BACKGROUND: The gut microbiota is a defense mechanism against colonization of multidrug-resistant organisms (MDROs), including carbapenem-resistant Enterobacteriacae (CRE). Gut dysbiosis caused by broad-spectrum antibiotics favors MDRO colonization and increased susceptibility of intestinal infectio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810869/ http://dx.doi.org/10.1093/ofid/ofz360.2069 |
_version_ | 1783462342959300608 |
---|---|
author | Dotson, Kierra M Gonzales-Luna, Anne J McPherson, Jacob Lancaster, Chris Endres, Bradley T Zasowski, Evan J Begum, Khurshida Alam, M Jahangir Garey, Kevin W |
author_facet | Dotson, Kierra M Gonzales-Luna, Anne J McPherson, Jacob Lancaster, Chris Endres, Bradley T Zasowski, Evan J Begum, Khurshida Alam, M Jahangir Garey, Kevin W |
author_sort | Dotson, Kierra M |
collection | PubMed |
description | BACKGROUND: The gut microbiota is a defense mechanism against colonization of multidrug-resistant organisms (MDROs), including carbapenem-resistant Enterobacteriacae (CRE). Gut dysbiosis caused by broad-spectrum antibiotics favors MDRO colonization and increased susceptibility of intestinal infections, including C. difficile infection (CDI). Increased CDI severity may increase the risk of bacterial translocation due to damage to colonic epithelial layer. The aim of this study was to assess CDI disease severity and subsequent risk for MDRO systemic infection. METHODS: This was a prospective, observational study of adult hospitalized patients tested for CDI at a large, university-affiliated tertiary care hospital. Patients with a history of systemic MDRO infection in the past 90-days of stool testing were excluded. Patients were stratified by test positivity (CDI vs. antibiotic-associated diarrhea (AAD)), as well as, CDI disease severity and followed for 30-days for subsequent MDRO infections defined as presence of MDRO cultures from systemic, normally sterile sites (blood, urine, cerebrospinal fluid). Stool samples were collected and grown for MDRO colonization. RESULTS: A total of 335 CDI-positive and 135 antibiotic-associated diarrhea (AAD) hospitalized patients were included. No differences were found in rates of MDRO colonization by test positivity or disease severity (overall 68% VRE, 53% Candida spp., 30.4% MRSA, and 1.8% CRE). Significantly more patients with severe CDI had higher rates of developing systemic MDROs compared with mild-moderate CDI and AAD (23.2%, n = 112 vs. 8.1%, n = 223 P < 0.001; vs. 11.9%, p = 0.018). Severe CDI was found to be an independent risk factor for subsequent systemic MDRO infection via logistic regression. CONCLUSION: Severe CDI disease is associated with an increased risk of systemic MDRO infections. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68108692019-10-28 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection Dotson, Kierra M Gonzales-Luna, Anne J McPherson, Jacob Lancaster, Chris Endres, Bradley T Zasowski, Evan J Begum, Khurshida Alam, M Jahangir Garey, Kevin W Open Forum Infect Dis Abstracts BACKGROUND: The gut microbiota is a defense mechanism against colonization of multidrug-resistant organisms (MDROs), including carbapenem-resistant Enterobacteriacae (CRE). Gut dysbiosis caused by broad-spectrum antibiotics favors MDRO colonization and increased susceptibility of intestinal infections, including C. difficile infection (CDI). Increased CDI severity may increase the risk of bacterial translocation due to damage to colonic epithelial layer. The aim of this study was to assess CDI disease severity and subsequent risk for MDRO systemic infection. METHODS: This was a prospective, observational study of adult hospitalized patients tested for CDI at a large, university-affiliated tertiary care hospital. Patients with a history of systemic MDRO infection in the past 90-days of stool testing were excluded. Patients were stratified by test positivity (CDI vs. antibiotic-associated diarrhea (AAD)), as well as, CDI disease severity and followed for 30-days for subsequent MDRO infections defined as presence of MDRO cultures from systemic, normally sterile sites (blood, urine, cerebrospinal fluid). Stool samples were collected and grown for MDRO colonization. RESULTS: A total of 335 CDI-positive and 135 antibiotic-associated diarrhea (AAD) hospitalized patients were included. No differences were found in rates of MDRO colonization by test positivity or disease severity (overall 68% VRE, 53% Candida spp., 30.4% MRSA, and 1.8% CRE). Significantly more patients with severe CDI had higher rates of developing systemic MDROs compared with mild-moderate CDI and AAD (23.2%, n = 112 vs. 8.1%, n = 223 P < 0.001; vs. 11.9%, p = 0.018). Severe CDI was found to be an independent risk factor for subsequent systemic MDRO infection via logistic regression. CONCLUSION: Severe CDI disease is associated with an increased risk of systemic MDRO infections. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810869/ http://dx.doi.org/10.1093/ofid/ofz360.2069 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Dotson, Kierra M Gonzales-Luna, Anne J McPherson, Jacob Lancaster, Chris Endres, Bradley T Zasowski, Evan J Begum, Khurshida Alam, M Jahangir Garey, Kevin W 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection |
title | 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection |
title_full | 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection |
title_fullStr | 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection |
title_full_unstemmed | 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection |
title_short | 2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection |
title_sort | 2391. increased risk of systemic infections with multidrug-resistant organisms in patients with severe clostridioides difficile infection |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810869/ http://dx.doi.org/10.1093/ofid/ofz360.2069 |
work_keys_str_mv | AT dotsonkierram 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT gonzaleslunaannej 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT mcphersonjacob 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT lancasterchris 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT endresbradleyt 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT zasowskievanj 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT begumkhurshida 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT alammjahangir 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection AT gareykevinw 2391increasedriskofsystemicinfectionswithmultidrugresistantorganismsinpatientswithsevereclostridioidesdifficileinfection |